CN102639693A - 乳动脉衍生细胞及在组织修复和再生中的应用方法 - Google Patents
乳动脉衍生细胞及在组织修复和再生中的应用方法 Download PDFInfo
- Publication number
- CN102639693A CN102639693A CN2010800551451A CN201080055145A CN102639693A CN 102639693 A CN102639693 A CN 102639693A CN 2010800551451 A CN2010800551451 A CN 2010800551451A CN 201080055145 A CN201080055145 A CN 201080055145A CN 102639693 A CN102639693 A CN 102639693A
- Authority
- CN
- China
- Prior art keywords
- cell
- artery
- imac
- digestion
- internal mammary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
抗体 | 制造商 | 目录号 |
CD34 | BD Pharmingen | 555821 |
CD44 | BD Pharmingen | 555478 |
CD45R | BD Pharmingen | 555489 |
CD117 | BD Pharmingen | 340529 |
CD141 | BD Pharmingen | 559781 |
CD31 | BD Pharmingen | 555446 |
CD133 | Miltenyi Biotech | 120-001-243 |
SSEA4 | R&D Systems | FAB1435P |
CD105 | SantaCruz Biotech | SC-21787 |
CD104 | BD Pharmingen | 555720 |
CD166 | BD Pharmingen | 559263 |
CD29 | BD Pharmingen | 555442 |
IgG-FITC | BD Pharmingen | 555748 |
IgG-PE | BD Pharmingen | 555749 |
CD34 | BD Pharmingen | 555821 |
CD44 | BD Pharmingen | 555478 |
CD45R | BD Pharmingen | 555489 |
CD117 | BD Pharmingen | 340529 |
CD141 | BD Pharmingen | 559781 |
CD31 | BD Pharmingen | 555446 |
CD49c | BD Pharmingen | 556025 |
CD73 | BD Pharmingen | 550257 |
CD90 | BD Pharmingen | 555596 |
HLA-I | BD Pharmingen | 555553 |
HLA-II | BD Pharmingen | 555558 |
CD133 | Miltenyi Biotech | 120-001-243 |
SSEA4 | R&D Systems | FAB1435P |
CD105 | SantaCruz Biotech | SC-21787 |
CD104 | BD Pharmingen | 555720 |
CD166 | BD Pharmingen | 559263 |
CD29 | BD Pharmingen | 555442 |
CD24 | BD Pharmingen | 555428 |
CD56 | AbCAM | MEM188 |
CD138 | BD Pharmingen | 550805 |
E-钙黏着蛋白 | BD Pharmingen | 612130 |
IgG-FITC | BD Pharmingen | 555748 |
IgG-PE | BD Pharmingen | 555749 |
细胞类型 | 抗体 | 细胞类型表达 | iMAC表达 |
内皮细胞祖细胞 | CD34 | 阳性 | 阴性 |
CD133 | 阳性 | 阴性 | |
CD45 | 阳性 | 阴性 | |
内皮细胞 | VE钙黏着蛋白 | 阳性 | 阴性 |
KDR/Flk1 | 阳性 | 阴性 | |
CD31 | 阳性 | 阴性 | |
CD104 | 阳性 | 阴性 | |
平滑肌细胞 | CD141 | 阳性 | 阴性 |
间充质干细胞 | CD10 | 阳性 | 阴性 |
CD29 | 阳性 | 阳性 | |
CD44 | 阳性 | 阳性 | |
CD73 | 阳性 | 阳性 | |
CD105 | 阳性 | 阴性 | |
CD166 | 阳性 | 阳性 | |
其他 | CD15 | 阳性 | 阴性 |
CD23 | 阳性 | 阴性 | |
CD24 | 阳性 | 阴性 | |
CD62p | 阳性 | 阴性 | |
CD73 | 阳性 | 阳性 | |
CD80 | 阳性 | 阴性 |
CD86 | 阳性 | 阴性 | |
CD117 | 阳性 | 阴性 | |
CD138 | 阳性 | 阴性 | |
HLA 1 | 阳性 | 阳性 | |
HLA 2 | 阳性 | 阴性 |
UniGene | 说明 |
Hs.311640 | 核糖体蛋白S27a |
Hs.525622 | V-akt鼠胸腺瘤病毒癌基因同源物1 |
Hs.1239 | 丙氨酰(膜)氨基肽酶,CD13 |
Hs.303649 | 趋化因子(C-C模体)配体2 |
Hs.532655 | 肝配蛋白-A2 |
Hs.516656 | 肝配蛋白-A3 |
Hs.76753 | 内皮糖蛋白(Osler-Rendu-Weber综合征1) |
Hs.468410 | 内皮细胞PAS结构域蛋白1 |
Hs.284244 | 成纤维细胞生长因子2(碱性) |
Hs.1420 | 成纤维细胞生长因子受体3 |
Hs.509554 | 低氧诱导因子1 |
Hs.512234 | 白细胞介素6(干扰素,β2) |
Hs.479756 | 激酶插入结构域受体 |
Hs.513617 | 基质金属肽酶2 |
Hs.131704 | 神经毡蛋白1 |
Hs.252820 | 胎盘生长因子 |
Hs.77274 | 纤溶酶原激活物,尿激酶 |
Hs.371147 | 血小板反应蛋白2 |
Hs.522632 | TIMP金属肽酶抑制剂1 |
Hs.652397 | TIMP金属肽酶抑制剂3 |
Hs.355899 | 肿瘤坏死因子受体超家族,成员12A |
Hs.631558 | 1型肌钙蛋白T(骨骼,慢) |
Hs.78781 | 血管内皮细胞生长因子B |
Hs.435215 | 血管内皮细胞生长因子C |
探针组代号 | 样品1 | 样品2 | 样品3 | 基因符号 | mRNA-登录号 | 平均值 | 标准偏差 |
2429144 | 14.42 | 14.47 | 14.51 | TRIM33 | NM_015906 | 14.5 | 0.05 |
2467968 | 13.90 | 13.90 | 14.10 | SOX11 | NM_003108 | 14.0 | 0.11 |
2431202 | 13.57 | 13.63 | 13.66 | NOTCH2 | NM_024408 | 13.6 | 0.05 |
2477142 | 13.19 | 13.25 | 13.18 | CRIM1 | NM_016441 | 13.2 | 0.04 |
2516866 | 12.80 | 12.91 | 12.91 | HOXD9 | NM_014213 | 12.9 | 0.07 |
2497821 | 12.41 | 12.59 | 12.37 | POU3F3 | NM_006236 | 12.5 | 0.12 |
分泌的蛋白质 |
β2微球蛋白 |
癌抗原19-9 |
肌酸激酶-MB |
ENA-78 |
内皮素-1 |
嗜伊红粒细胞趋化蛋白 |
脂肪酸结合蛋白 |
铁蛋白 |
碱性FGF |
IL-6 |
IL-8 |
胰岛素 |
MCP-1 |
PAI-1 |
干细胞因子 |
TIMP-1 |
VCAM-1 |
VEGF |
组编号 | 动物数目 | 植入物数目 | 试验材料 |
1 | 3 | 6 | 单独Matrigel |
2 | 3 | 6 | Matrigel+iMAC |
3 | 3 | 6 | Matrigel+bFGF |
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24722809P | 2009-09-30 | 2009-09-30 | |
US61/247228 | 2009-09-30 | ||
PCT/US2010/049850 WO2011041186A1 (en) | 2009-09-30 | 2010-09-22 | Mammary artery derived cells and methods of use in tissue repair and regeneration |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102639693A true CN102639693A (zh) | 2012-08-15 |
CN102639693B CN102639693B (zh) | 2015-08-12 |
Family
ID=43127664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080055145.1A Expired - Fee Related CN102639693B (zh) | 2009-09-30 | 2010-09-22 | 乳动脉衍生细胞及在组织修复和再生中的应用方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US8323972B2 (zh) |
EP (1) | EP2483393B1 (zh) |
JP (1) | JP5893562B2 (zh) |
CN (1) | CN102639693B (zh) |
AU (2) | AU2010300871B2 (zh) |
CA (1) | CA2781520C (zh) |
IN (1) | IN2012DN02760A (zh) |
WO (1) | WO2011041186A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8323972B2 (en) | 2009-09-30 | 2012-12-04 | Advanced Technologies And Regenerative Medicine, Llc | Mammary artery derived cells and methods of use in tissue repair and regeneration |
US8889413B2 (en) | 2009-09-30 | 2014-11-18 | DePuy Synthes Products, LLC | Mammary artery derived cells and methods of use in tissue repair and regeneration |
US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
US20130209418A1 (en) | 2012-02-15 | 2013-08-15 | Johnson & Johnson Regenerative Therapeutics, Llc | Methods and composition related to brown adipose-like cells |
CN106661552B (zh) * | 2014-07-11 | 2020-07-07 | 玛土撤拉有限公司 | 心脏细胞培养材料 |
JP7165330B2 (ja) * | 2017-05-08 | 2022-11-04 | 慶應義塾 | 多層構造体とその製造方法及び利用方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
US5574205A (en) | 1989-07-25 | 1996-11-12 | Cell Genesys | Homologous recombination for universal donor cells and chimeric mammalian hosts |
US5612205A (en) | 1990-08-29 | 1997-03-18 | Genpharm International, Incorporated | Homologous recombination in mammalian cells |
US5342761A (en) * | 1990-10-01 | 1994-08-30 | Research Development Foundation | Oncofetal gene, gene product and uses therefor |
US5286632A (en) * | 1991-01-09 | 1994-02-15 | Jones Douglas H | Method for in vivo recombination and mutagenesis |
WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5320962A (en) * | 1992-07-22 | 1994-06-14 | Duke University | DNA encoding the human A1 adenosine receptor |
AU2003270051A1 (en) | 2002-08-29 | 2004-03-19 | Baylor College Of Medicine | Heart derived cells for cardiac repair |
ES2265199B1 (es) | 2003-06-12 | 2008-02-01 | Cellerix, S.L. | Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones. |
ATE494360T1 (de) | 2004-07-20 | 2011-01-15 | Univ Case Western Reserve | Neue zellpopulationen und deren anwendungen |
JP4819809B2 (ja) * | 2004-07-28 | 2011-11-24 | ユニベルシテ・ルネ・デカルト・パリ 5 | 血管幹細胞及びその使用 |
US20090124007A1 (en) * | 2006-11-15 | 2009-05-14 | Seoul National University Industry Foundation | Method for the Simultaneous Primary-Isolation and Expansion of Endothelial Stem/Progenitor Cell and Mesenchymal Stem Cell Derived From Mammal Including Human Umbilical Cord |
WO2009134991A2 (en) * | 2008-04-30 | 2009-11-05 | Ethicon, Inc. | Tissue engineered blood vessel |
US8323972B2 (en) | 2009-09-30 | 2012-12-04 | Advanced Technologies And Regenerative Medicine, Llc | Mammary artery derived cells and methods of use in tissue repair and regeneration |
-
2010
- 2010-09-20 US US12/885,855 patent/US8323972B2/en active Active
- 2010-09-22 WO PCT/US2010/049850 patent/WO2011041186A1/en active Application Filing
- 2010-09-22 CA CA2781520A patent/CA2781520C/en not_active Expired - Fee Related
- 2010-09-22 AU AU2010300871A patent/AU2010300871B2/en not_active Ceased
- 2010-09-22 CN CN201080055145.1A patent/CN102639693B/zh not_active Expired - Fee Related
- 2010-09-22 EP EP10760857.2A patent/EP2483393B1/en not_active Not-in-force
- 2010-09-22 JP JP2012532193A patent/JP5893562B2/ja not_active Expired - Fee Related
- 2010-09-22 IN IN2760DEN2012 patent/IN2012DN02760A/en unknown
-
2012
- 2012-11-08 US US13/671,720 patent/US9650611B2/en active Active
-
2014
- 2014-07-02 AU AU2014203616A patent/AU2014203616B2/en not_active Ceased
Non-Patent Citations (2)
Title |
---|
GIANANDREA PASQUINELLI ET AL.: "Thoracic Aortas from Multiorgan Donors Are Suitable for Obtaining Resident Angiogenic Mesenchymal Stromal Cells", 《STEM CELLS》 * |
ZENGIN E, ET AL.: "Vascular wall resident progenitor cells: a source for postnatal vasculogenesis", 《DEVELOPMENT》 * |
Also Published As
Publication number | Publication date |
---|---|
AU2010300871B2 (en) | 2014-09-25 |
WO2011041186A1 (en) | 2011-04-07 |
AU2010300871A1 (en) | 2012-05-03 |
IN2012DN02760A (zh) | 2015-09-18 |
AU2014203616B2 (en) | 2015-10-01 |
EP2483393B1 (en) | 2018-08-08 |
CN102639693B (zh) | 2015-08-12 |
US8323972B2 (en) | 2012-12-04 |
US20110076769A1 (en) | 2011-03-31 |
AU2014203616A1 (en) | 2014-07-17 |
US9650611B2 (en) | 2017-05-16 |
US20130065305A1 (en) | 2013-03-14 |
CA2781520C (en) | 2018-12-04 |
EP2483393A1 (en) | 2012-08-08 |
JP5893562B2 (ja) | 2016-03-23 |
JP2013506420A (ja) | 2013-02-28 |
CA2781520A1 (en) | 2011-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bernstein et al. | Stem cell therapy for cardiac disease | |
Kelm et al. | Scaffold-free cell delivery for use in regenerative medicine | |
Colazzo et al. | Shear stress and VEGF enhance endothelial differentiation of human adipose-derived stem cells | |
US11045502B2 (en) | Method of isolating cells for therapy and prophylaxis | |
EP3124600B1 (en) | Method for generating a cell condensate for self-organisation | |
Haack‐Sorensen et al. | Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy | |
CN101842105B (zh) | 来自尿的祖细胞及其使用方法 | |
CN102639693B (zh) | 乳动脉衍生细胞及在组织修复和再生中的应用方法 | |
CN101437576A (zh) | 使用产后衍生细胞治疗外周血管疾病 | |
CN107028980A (zh) | 用于治疗心脏疾病的药物组合物 | |
Hong et al. | Skeletal extracellular matrix supports cardiac differentiation of embryonic stem cells: a potential scaffold for engineered cardiac tissue | |
CN101148656B (zh) | 一种组织工程化肝单元的构建方法 | |
CN101451124A (zh) | 人脐带间充质干细胞创面涂抹剂的制备和储存应用方法 | |
Liang et al. | Gelatin methacryloyl-alginate core-shell microcapsules as efficient delivery platforms for prevascularized microtissues in endodontic regeneration | |
CN104937095A (zh) | 肾细胞群及其用途 | |
Dergilev et al. | Comparison of cardiac stem cell sheets detached by Versene solution and from thermoresponsive dishes reveals similar properties of constructs | |
CN108135942A (zh) | 基于脂肪来源的干细胞的干细胞疗法 | |
CN105473707A (zh) | 成体心脏干细胞群 | |
Melero‐Martin et al. | An in vivo experimental model for postnatal vasculogenesis | |
Crisostomo et al. | Allogeneic cardiac stem cell administration for acute myocardial infarction | |
Sun et al. | Isolation of ready-made rat microvessels and its applications in effective in vivo vascularization and in angiogenic studies in vitro | |
US8889413B2 (en) | Mammary artery derived cells and methods of use in tissue repair and regeneration | |
CN105106239A (zh) | 使用产后衍生细胞治疗外周血管疾病 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HAND INNOVATIONS LLC Free format text: FORMER OWNER: DEPUY SPINE INC. Effective date: 20140702 Owner name: DEPUYI ORTHOPEDIC COMPANY Free format text: FORMER OWNER: ADVANCED TECHNOLOGIES AND REGE Effective date: 20140702 Owner name: DEPUY SPYER CORP. Free format text: FORMER OWNER: DEPUYI ORTHOPEDIC COMPANY Effective date: 20140702 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Massachusetts, USA Applicant after: DEPUY SYNTHES PRODUCTS, LLC Address before: American Florida Applicant before: HAND INNOVATIONS, LLC Address after: Massachusetts, USA Applicant after: Depp Speyer Iraq LLC Address before: Massachusetts, USA Applicant before: DEPUY SPINE, Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: DEPUY SPYER CORP. TO: DEPUY SPINE INC. Free format text: CORRECT: APPLICANT; FROM: HAND INNOVATIONS LLC TO: DEPUY SYNTHES PRODUCTS LLC |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140702 Address after: American Florida Applicant after: HAND INNOVATIONS, LLC Address before: Massachusetts, USA Applicant before: Depp Speyer Iraq LLC Effective date of registration: 20140702 Address after: Massachusetts, USA Applicant after: DEPUY SPINE, Inc. Address before: indiana Applicant before: Depp Iraq orthopedic Co. Effective date of registration: 20140702 Address after: indiana Applicant after: Depp Iraq orthopedic Co. Address before: Massachusetts, USA Applicant before: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150812 |